121
Participants
Start Date
January 12, 2018
Primary Completion Date
March 31, 2025
Study Completion Date
March 31, 2025
avacincaptad pegol
Intravitreal Injection
Sham
Intravitreal Injection
Budapest Retina Institute, Budapest
University of Debrecen DE KK Szemészeti Klinika, Debrecen
Szegedi Tudomanyegyetem, Szent-Gyorgyi Albert Klinikai Kozpont, Szemeszeti Klinika, Szeged
Ganglion Medical Center, Pécs
UPMC Eye Center, Pittsburgh
Wills Eye Hospital/Mid Atlantic Retina, Philadelphia
Ospedale San Raffaele, Milan
Wilmer Eye Institute, Johns Hopkins, Baltimore
Palmetto Retina Center, West Columbia
Retina Specialty Institute, Pensacola
VitreoRetinal Associates, Gainesville
AOU Policlinico Sant'Orsola Malpighi, U.O. Oftalmologia,, Bologna
University of Michigan/Kellogg Eye Center, Ann Arbor
Azienda Ospedaliera Universitaria Careggi, Florence
University of Bonn, Bonn
The Retina Center, Minneapolis
Hopital de la Croix-Rousse, Lyon
University of Tuebingen, Tübingen
Centre ophtalmologique des Quinzes Vingts, Paris
Retina Foundation of the Southwest, Dallas
Strategic Clinical Research Group, Willow Park
Austin Retina Associates, Austin
University of Campania Luigi Vanvitelli Eye Clinic, Naples
Augenklinik der LMU München, München
University of Utah John A. Moran Eye Center, Salt Lake City
Retinal Research Institute, Phoenix
Jules Stein Eye Institute/ David Geffen School of Medicine, Los Angeles
Creteil University Eye Clinic University Paris EST, Créteil
Casey Eye Institute/Oregon Health & Science University, Portland
Rambam Health Care Campus, Haifa
Rabin Medical Center, Beilinson campus, Petah Tikva
Tel-Aviv Sourasky Medical Center, Ichilov Hospital, Tel Aviv
Kaplan Medical Center, Rehovot
Hadassah University Hospital, Jerusalem
Ophthalmic Consultants of Boston, Boston
Retina Center of NJ, LLC., Bloomfield
Semmelweis Egyetem, Budapest
Fondazione Policlinico Tor Vergata, UOSD Patologie Retiniche, Rome
Institut de la Macula, Barcelona
Princess Alexandra Eye Pavillion, Edinburgh
Moorfields Eye Hospital, London
Astellas Pharma Global Development, Inc.
INDUSTRY